A mostrar 1 - 5 resultados de 5 para a pesquisa 'Seyed Reza Mousavi (13223324)', tempo de pesquisa: 0.01seg Refinar resultados
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. Por Seyed Reza Mousavi (13223324)

    Publicado em 2025
    Adic. favoritos
    Na minha lista:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. Por Seyed Reza Mousavi (13223324)

    Publicado em 2025
    Adic. favoritos
    Na minha lista:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. Por Seyed Reza Mousavi (13223324)

    Publicado em 2025
    Adic. favoritos
    Na minha lista:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. Por Seyed Reza Mousavi (13223324)

    Publicado em 2025
    Adic. favoritos
    Na minha lista:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. Por Seyed Reza Mousavi (13223324)

    Publicado em 2025
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: